Unfortunately, it didnt work in every last person, which is why its not included in my recommendations
But in practice, and especially with regard to synthetic and recombinant peptide forms, there are some considerable potential safety concerns: Immunogenicity Most notably, per a 2020 assessment on therapeutic peptide safety, synthetic and recombinant peptides pose the risk of immunogenicity the ability of a substance to provoke an immune response.15 An immunogenicity-inducing peptide, when introduced to the body, would cause the bodys immune system to perceive the peptide not as a medication but as a threat
Research peptide costs Peptides sold as research chemicals for laboratory use cost significantly less than clinical peptides
Understanding the trade-offs helps you make informed decisions
After IM injections of 20, 100, and 500 g/kg of BPC157 in rats and 6, 30, and 150 g/kg of BPC157 in beagles, plasma BPC157 reached its peak rapidly (within 9 min)
Order two 10mg vials rather than five 2mg vials
